bristoldrv Posted July 26, 2018 Report Share Posted July 26, 2018 Bristol-Myers Drops After Cancer Drug Combo Rejected in Europe BloombergBristol-Myers Squibb Co.'s euphoria from a solid second-quarter earnings report lasted less than four hours. During a call discussing the company's ... View the full article Quote Link to comment Share on other sites More sharing options...